Glutathione and redox signaling in substance abuse

Biomedicine and Pharmacotherapy

Volumn 68, Issue 6, 2014, Pages 799-807

  Uys, Joachim D ^a   Mulholland, Patrick J ^b   Townsend, Danyelle M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Addiction; Glutathione; Glutathione S transferase Pi; Oxidative stress; Redox; S glutathionylation

Indexed keywords

ALCOHOL; CELL SURFACE PROTEIN; COCAINE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; METHAMPHETAMINE; PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; COCAINE DEPENDENCE; ENZYME SPECIFICITY; HOMEOSTASIS; HUMAN; METHAMPHETAMINE DEPENDENCE; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; NUCLEOPHILICITY; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SUBSTANCE ABUSE; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SUBSTANCE-RELATED DISORDERS;

ANIMALS; GLUTATHIONE; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS;

EID: 84908101585     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.06.001     Document Type: Review

References (101)

1. Townsend D.M. S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 2007, 7:313-324.
2. Xiong Y., Uys J.D., Tew K.D., Townsend D.M. S-glutathionylation: from molecular mechanisms to health outcomes. Antioxid Redox Signal 2011, 15:233-270.
3. Grek C.L., Zhang J., Manevich Y., Townsend D.M., Tew K.D. Causes and consequences of cysteine S-glutathionylation. J Biol Chem 2013, 288:26497-26504.
4. Pompella A. Redox events and cell membrane proteins. Arch Biochem Biophys 2005, 434:1-2.
5. Corti A., Paolicchi A., Franzini M., Dominici S., Casini A.F., Pompella A. The S-thiolating activity of membrane gamma-glutamyltransferase: formation of cysteinyl-glycine mixed disulfides with cellular proteins and in the cell microenvironment. Antioxid Redox Signal 2005, 7:911-918.
6. Mann K., Agartz I., Harper C., Shoaf S., Rawlings R.R., Momenan R., et al. Neuroimaging in alcoholism: ethanol and brain damage. Alcohol Clin Exp Res 2001, 25:104S-109S.
7. Kousik S.M., Napier T.C., Carvey P.M. The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol 2012, 3:121.
8. McIlwain C.C., Townsend D.M., Tew K.D. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006, 25:1639-1648.
9. Adler V., Yin Z., Fuchs S.Y., Benezra M., Rosario L., Tew K.D., et al. Regulation of JNK signaling by GSTp. EMBO J 1999, 18:1321-1334.
10. Adler V., Yin Z., Tew K.D., Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999, 18:6104-6111.
11. Wang T., Arifoglu P., Ronai Z., Tew K.D. Glutathione S-transferase P 1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 2001, 276:20999-21003.
12. Townsend D.M., Manevich Y., He L., Hutchens S., Pazoles C.J., Tew K.D. Novel role for glutathione S-transferase pi. Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 2009, 284:436-445.
13. Manevich Y., Hutchens S., Tew K.D., Townsend D.M. Allelic variants of glutathione S-transferase P 1-1 differentially mediate the peroxidase function of peroxiredoxin VI and alter membrane lipid peroxidation. Free Radic Biol Med 2012, 54C:62-70.
14. Anathy V., Roberson E., Cunniff B., Nolin J.D., Hoffman S., Spiess P., et al. Oxidative processing of latent Fas in the endoplasmic reticulum controls the strength of apoptosis. Mol Cell Biol 2012, 32:3464-3478.
15. Anathy V., Roberson E.C., Guala A.S., Godburn K.E., Budd R.C., Janssen-Heininger Y.M. Redox-based regulation of apoptosis: S-glutathionylation as a regulatory mechanism to control cell death. Antioxid Redox Signal 2012, 16:496-505.
16. Manevich Y., Feinstein S.I., Fisher A.B. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc Natl Acad Sci U S A 2004, 101:3780-3785.
17. Janssen-Heininger Y.M., Aesif S.W., van der Velden J., Guala A.S., Reiss J.N., Roberson E.C., et al. Regulation of apoptosis through cysteine oxidation: implications for fibrotic lung disease. Ann N Y Acad Sci 2010, 1203:23-28.
18. Shelton M.D., Chock P.B., Mieyal J.J. Glutaredoxin: role in reversible protein S-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal 2005, 7:348-366.
19. Sengupta R., Holmgren A. Thioredoxin and thioredoxin reductase in relation to reversible S-nitrosylation. Antioxid Redox Signal 2013, 18:259-269.
20. Gould N., Doulias P.T., Tenopoulou M., Raju K., Ischiropoulos H. Regulation of protein function and signaling by reversible cysteine S-nitrosylation. J Biol Chem 2013, 288:26473-26479.
21. Doulias P.T., Greene J.L., Greco T.M., Tenopoulou M., Seeholzer S.H., Dunbrack R.L., et al. Structural profiling of endogenous S-nitrosocysteine residues reveals unique features that accommodate diverse mechanisms for protein S-nitrosylation. Proc Natl Acad Sci U S A 2010, 107:16958-16963.
22. Anand P., Stamler J.S. Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease. J Mol Med 2012, 90:233-244.
23. Kallis G.B., Holmgren A. Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli. J Biol Chem 1980, 255:10261-10265.
24. Holmgren A. Thioredoxin. Ann Rev Biochem 1985, 54:237-271.
25. Benhar M., Forrester M.T., Hess D.T., Stamler J.S. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 2008, 320:1050-1054.
26. Dringen R., Pfeiffer B., Hamprecht B. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 1999, 19:562-569.
27. O'Connor E., Devesa A., Garcia C., Puertes I.R., Pellin A., Vina J.R. Biosynthesis and maintenance of GSH in primary astrocyte cultures: role of L-cystine and ascorbate. Brain Res 1995, 680:157-163.
28. Baker D.A., McFarland K., Lake R.W., Shen H., Tang X.C., Toda S., et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 2003, 6:743-749.
29. Madayag A., Lobner D., Kau K.S., Mantsch J.R., Abdulhameed O., Hearing M., et al. Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine. J Neurosci 2007, 27:13968-13976.
30. Devi B.G., Chan A.W. Cocaine-induced increase of Mn-SOD in adult rat liver cells. Life Sci 1997, 61:1245-1251.
31. Labib R., Turkall R., Abdel-Rahman M.S. Inhibition of cocaine oxidative metabolism attenuates endotoxin potentiation of cocaine mediated hepatotoxicity. Toxicology 2002, 179:9-19.
32. Labib R., Turkall R., Abdel-Rahman M.S. Endotoxin potentiates the hepatotoxicity of cocaine in male mice. J Toxicol Environ Health. Part A 2002, 65:977-993.
33. Pacifici R., Fiaschi A.I., Micheli L., Centini F., Giorgi G., Zuccaro P., et al. Immunosuppression and oxidative stress induced by acute and chronic exposure to cocaine in rat. Int Immunopharmacol 2003, 3:581-592.
34. Visalli T., Turkall R., Abdel-Rahman M.S. Cocaine hepatotoxicity and its potentiation by lipopolysaccharide: treatment and gender effects. Int J Toxicol 2004, 23:163-170.
35. Muriach M., Lopez-Pedrajas R., Barcia J.M., Sanchez-Villarejo M.V., Almansa I., Romero F.J. Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate. J Neurochem 2010, 114:675-684.
36. Macedo D.S., Vasconcelos S.M., Andrade-Neto M., Belchior L.D., Honorio Junior J.E., Goncalves D.O., et al. Cocaine-induced status epilepticus and death generate oxidative stress in prefrontal cortex and striatum of mice. Neurochem Int 2010, 56:183-187.
37. Dietrich J.B., Mangeol A., Revel M.O., Burgun C., Aunis D., Zwiller J. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology 2005, 48:965-974.
38. Uys J.D., Knackstedt L., Hurt P., Tew K.D., Manevich Y., Hutchens S., et al. Cocaine-induced adaptations in cellular redox balance contributes to enduring behavioral plasticity. Neuropsychopharmacology 2011, 36:2551-2560.
39. Ali-Osman F., Akande O., Antoun G., Mao J.X., Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997, 272:10004-10012.
40. Pandya U., Srivastava S.K., Singhal S.S., Pal A., Awasthi S., Zimniak P., et al. Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil. Biochem Biophys Res Commun 2000, 278:258-262.
41. Self D.W., Genova L.M., Hope B.T., Barnhart W.J., Spencer J.J., Nestler E.J. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci 1998, 18:1848-1859.
42. Humphries K.M., Juliano C., Taylor S.S. Regulation of cAMP-dependent protein kinase activity by glutathionylation. J Biol Chem 2002, 277:43505-43511.
43. Seiwell A.P., Reveron M.E., Duvauchelle C.L. Increased accumbens Cdk5 expression in rats after short-access to self-administered cocaine, but not after long-access sessions. Neurosci Lett 2007, 417:100-105.
44. Taylor J.R., Lynch W.J., Sanchez H., Olausson P., Nestler E.J., Bibb J.A. Inhibition of Cdk5 in the nucleus accumbens enhances the locomotor-activating and incentive-motivational effects of cocaine. Proc Natl Acad Sci U S A 2007, 104:4147-4152.
45. Sun K.H., Chang K.H., Clawson S., Ghosh S., Mirzaei H., Regnier F., et al. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. J Neurochem 2011, 118:902-914.
46. Mardikian P.N., LaRowe S.D., Hedden S., Kalivas P.W., Malcolm R.J. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:389-394.
47. LaRowe S.D., Mardikian P., Malcolm R., Myrick H., Kalivas P., McFarland K., et al. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict 2006, 15:105-110.
48. LaRowe S.D., Kalivas P.W., Nicholas J.S., Randall P.K., Mardikian P.N., Malcolm R.J. A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict 2013, 22:443-452.
49. Moussawi K., Pacchioni A., Moran M., Olive M.F., Gass J.T., Lavin A., et al. N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci 2009, 12:182-189.
50. Moussawi K., Zhou W., Shen H., Reichel C.M., See R.E., Carr D.B., et al. Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse. Proc Natl Acad Sci U S A 2011, 108:385-390.
51. Reichel C.M., Moussawi K., Do P.H., Kalivas P.W., See R.E. Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking. J Pharmacol Exp Ther 2011, 337:487-493.
52. Kupchik Y.M., Moussawi K., Tang X.C., Wang X., Kalivas B.C., Kolokithas R., et al. The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine. Biol Psychiatry 2012, 71:978-986.
53. Schmaal L., Veltman D.J., Nederveen A., van den Brink W., Goudriaan A.E. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology 2012, 37:2143-2152.
54. UNDCP World Drug Report 2012 2012, United Nations Office on Drugs and Crime.
55. Iversen L. Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 2006, 147(Suppl.1):S82-S88.
56. Sulzer D., Sonders M.S., Poulsen N.W., Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005, 75:406-433.
57. Sandoval V., Riddle E.L., Hanson G.R., Fleckenstein A.E. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits. J Pharmacol Exper Ther 2003, 304:1181-1187.
58. LaVoie M.J., Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 1999, 19:1484-1491.
59. Kita T., Takahashi M., Kubo K., Wagner G.C., Nakashima T. Hydroxyl radical formation following methamphetamine administration to rats. Pharmacol Toxicol 1999, 85:133-137.
60. Cadet J.L., Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 1998, 32:117-131.
61. Wiese A.G., Pacifici R.E., Davies K.J. Transient adaptation of oxidative stress in mammalian cells. Arch Biochem Biophys 1995, 318:231-240.
62. Jang J.H., Surh Y.J. Possible role of NF-kappaB in Bcl-X(L) protection against hydrogen peroxide-induced PC12 cell death. Redox Rep 2004, 9:343-348.
63. Chandramani Shivalingappa P., Jin H., Anantharam V., Kanthasamy A., Kanthasamy A. N-Acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells. Parkinson Dis 2012, 2012:424285.
64. Achat-Mendes C., Anderson K.L., Itzhak Y. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists. Neuropsychopharmacology 2007, 32:531-541.
65. Harold C., Wallace T., Friedman R., Gudelsky G., Yamamoto B. Methamphetamine selectively alters brain glutathione. Eur J Pharmacol 2000, 400:99-102.
66. Mirecki A., Fitzmaurice P., Ang L., Kalasinsky K.S., Peretti F.J., Aiken S.S., et al. Brain antioxidant systems in human methamphetamine users. J Neurochem 2004, 89:1396-1408.
67. Hashimoto T., Hashimoto K., Matsuzawa D., Shimizu E., Sekine Y., Inada T., et al. A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population. Am J Med Genet B 2005, 135B:5-9.
68. Eyerman D.J., Yamamoto B.K. A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. J Neurochem 2007, 103:1219-1227.
69. Zhang X., Banerjee A., Banks W.A., Ercal N. N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res 2009, 1275:87-95.
70. Fukami G., Hashimoto K., Koike K., Okamura N., Shimizu E., Iyo M. Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Res 2004, 1016:90-95.
71. Grant J.E., Odlaug B.L., Kim S.W. A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. Eur Neuropsychopharmacol 2010, 20:823-828.
72. Fadda F., Rossetti Z.L. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 1998, 56:385-431.
73. Zahr N.M., Kaufman K.L., Harper C.G. Clinical and pathological features of alcohol-related brain damage. Nat Rev 2011, 7:284-294.
74. Crews F.T., Nixon K. Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol 2009, 44:115-127.
75. Tiwari V., Chopra K. Resveratrol abrogates alcohol-induced cognitive deficits by attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat brain. Neurochem Int 2013, 62:861-869.
76. Qin L., Crews F.T. NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration. J Neuinflammation 2012, 9:5.
77. Rendon-Ramirez A., Cortes-Couto M., Martinez-Rizo A.B., Muniz-Hernandez S., Velazquez-Fernandez J.B. Oxidative damage in young alcohol drinkers: a preliminary study. Alcohol 2013, 47:501-504.
78. Sommavilla M., Sanchez-Villarejo M.V., Almansa I., Sanchez-Vallejo V., Barcia J.M., Romero F.J., et al. The effects of acute ethanol exposure and ageing on rat brain glutathione metabolism. Free Radic Res 2012, 46:1076-1081.
79. Scapagnini G., Ravagna A., Bella R., Colombrita C., Pennisi G., Calvani M., et al. Long-term ethanol administration enhances age-dependent modulation of redox state in brain and peripheral organs of rat: protection by acetyl carnitine. Int J Tissue React 2002, 24:89-96.
80. 2+-ATPase but induces oxidative stress in rat. J Membr Biol 2010, 237:51-58.
81. Amanvermez R., Agara E. Does ascorbate/L-Cys/L-Met mixture protect different parts of the rat brain against chronic alcohol toxicity?. Adv Ther 2006, 23:705-718.
82. Peter N.K.J., Chiramel R.S.A. Effect of alcohol withdrawl on glutathione S-transferase, total antioxidant capacity and amylase in blood and saliva of alcohol-dependent males. J Clin Diagn Res 2013, 7:797-800.
83. Shivashankara A.R., Azmidah A., Haniadka R., Rai M.P., Arora R., Baliga M.S. Dietary agents in the prevention of alcohol-induced hepatotoxicty: preclinical observations. Food Funct 2012, 3:101-109.
84. Muttigi M.S., Prabhu L.S., Kedage V., Prakash M., Shetty J.K., Virupaksha D. Glutathione-S-Transferase activity and total thiol status in chronic alcohol abusers before and 30 days after alcohol abstinence. J Health Allied Scs 2009, 8:1-5.
85. Singh M., Ahharwal H.K., Aggarwal S.K. Significance of the glutathione S-transferase activity and the total thiols status in chronic alcoholics. J Clin Diagn Res 2012, 6:31-33.
86. Bjork K., Saarikoski S.T., Arlinde C., Kovanen L., Osei-Hyiaman D., Ubaldi M., et al. Glutathione-S-transferase expression in the brain: possible role in ethanol preference and longevity. FASEB J 2006, 20:1826-1835.
87. Liang T., Habegger K., Spence J.P., Foroud T., Ellison J.A., Lumeng L., et al. Glutathione S-transferase 8-8 expression is lower in alcohol-preferring than in alcohol-non-preferring rats. Alcohol Clin Exp Res 2004, 28:1622-1628.
88. Covolo L., Gelatti U., Talamini R., Garte S., Trevisi P., Franceschi S., et al. Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy). Cancer Causes Control 2005, 16:831-838.
89. Mulholland P.J. K(Ca)2 channels: novel therapeutic targets for treating alcohol withdrawal and escalation of alcohol consumption. Alcohol 2012, 46:309-315.
90. Soden M.E., Jones G.L., Sanford C.A., Chung A.S., Guler A.D., Chavkin C., et al. Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation. Neuron 2013, 80:997-1009.
91. Mulholland P.J., Becker H.C., Woodward J.J., Chandler L.J. Small conductance calcium-activated potassium type 2 channels regulate alcohol-associated plasticity of glutamatergic synapses. Biol Psychiatry 2011, 69:625-632.
92. Hopf F.W., Bowers M.S., Chang S.J., Chen B.T., Martin M., Seif T., et al. Reduced nucleus accumbens SK channel activity enhances alcohol seeking during abstinence. Neuron 2010, 65:682-694.
93. Hopf F.W., Martin M., Chen B.T., Bowers M.S., Mohamedi M.M., Bonci A. Withdrawal from intermittent ethanol exposure increases probability of burst firing in VTA neurons in vitro. J Neurophysiol 2007, 98:2297-2310.
94. Ishikawa M., Mu P., Moyer J.T., Wolf J.A., Quock R.M., Davies N.M., et al. Homeostatic synapse-driven membrane plasticity in nucleus accumbens neurons. J Neurosci 2009, 29:5820-5831.
95. Dalle-Donne I., Rossi R., Colombo G., Giustarini D., Milzani A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci 2009, 34:85-96.
96. Nakamura T., Lipton S.A. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ 2011, 18:1478-1486.
97. Bonassoli V.T., Contardi E.B., Milani H., de Oliveira R.M. Effects of nitric oxide synthase inhibition in the dorsolateral periaqueductal gray matter on ethanol withdrawal-induced anxiety-like behavior in rats. Psychopharmacology 2013, 228:487-498.
98. Uzbay I.T., Erden B.F., Tapanyigit E.E., Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci 1997, 61:2197-2209.
99. Adams M.L., Sewing B.N., Chen J., Meyer E.R., Cicero T.J. Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol Clin Exp Res 1995, 19:195-199.
100. 2 levels prevents voluntary ethanol intake in mice: a role for the brain catalase-H O system in alcohol binge drinking. Alcohol Clin Exp Res 2014, 38(1):60-67.
101. Peana A.T., Muggironi G., Fois G., Diana M. Alpha-lipoic acid reduces ethanol self-administration in rats. Alcohol Clin Exp Res 2013, 37:1816-1822.